[go: up one dir, main page]

MX2019008419A - Métodos de fabricación de harinas de nueces y formulaciones para inmunoterapia oral. - Google Patents

Métodos de fabricación de harinas de nueces y formulaciones para inmunoterapia oral.

Info

Publication number
MX2019008419A
MX2019008419A MX2019008419A MX2019008419A MX2019008419A MX 2019008419 A MX2019008419 A MX 2019008419A MX 2019008419 A MX2019008419 A MX 2019008419A MX 2019008419 A MX2019008419 A MX 2019008419A MX 2019008419 A MX2019008419 A MX 2019008419A
Authority
MX
Mexico
Prior art keywords
formulations
methods
nut
manufacture
flours
Prior art date
Application number
MX2019008419A
Other languages
English (en)
Inventor
Joy Simon Reyna
William BIRRINGER Nicholas
Original Assignee
Aimmune Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aimmune Therapeutics Inc filed Critical Aimmune Therapeutics Inc
Publication of MX2019008419A publication Critical patent/MX2019008419A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
    • A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente tecnología se refiere generalmente a métodos de fabricación de harinas y/o formulaciones de nueces, harinas de nueces ultra bajas en grasa y usos para formulaciones de harina de nueces. En particular, varias modalidades están dirigidas a métodos de fabricación de formulaciones de harina de cacahuate o frutos secos ultra bajas en grasa para la administración oral en inmunoterapia de sujetos afectados por alergias.
MX2019008419A 2017-01-13 2018-01-12 Métodos de fabricación de harinas de nueces y formulaciones para inmunoterapia oral. MX2019008419A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762446147P 2017-01-13 2017-01-13
PCT/US2018/013612 WO2018132733A1 (en) 2017-01-13 2018-01-12 Methods of manufacture of nut flours and formulations for oral immunotherapy

Publications (1)

Publication Number Publication Date
MX2019008419A true MX2019008419A (es) 2019-12-02

Family

ID=62838507

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019008419A MX2019008419A (es) 2017-01-13 2018-01-12 Métodos de fabricación de harinas de nueces y formulaciones para inmunoterapia oral.

Country Status (10)

Country Link
US (2) US20180200361A1 (es)
EP (1) EP3568027A4 (es)
JP (2) JP2020514306A (es)
CN (1) CN110381749A (es)
AU (2) AU2018207167A1 (es)
CA (1) CA3050093A1 (es)
IL (1) IL267882A (es)
MX (1) MX2019008419A (es)
SG (2) SG10201913846XA (es)
WO (1) WO2018132733A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
DK3482771T3 (da) 2013-03-14 2023-03-20 Nestle Sa Fremstilling af jordnøddeformuleringer til oral desensibilisering
WO2014159609A1 (en) 2013-03-14 2014-10-02 Allergen Research Corporation Peanut formulations and uses thereof
AU2015306683B2 (en) 2014-08-25 2021-11-25 Societe Des Produits Nestle S.A. Egg protein formulations and methods of manufacture thereof
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
EP3654778A1 (en) 2017-07-18 2020-05-27 Before Brands, Inc. Methods for making mixed allergen compositions
MX2020004683A (es) 2017-11-02 2020-08-13 Aimmune Therapeutics Inc Metodos de inmunoterapia oral.
AU2019310602A1 (en) 2018-07-27 2021-02-04 Societe Des Produits Nestle S.A. Oral immunotherapy unit dose dispensing systems and methods
WO2020037151A1 (en) 2018-08-16 2020-02-20 Aimmune Therapeutics, Inc. Peanut oral immunotherapy with maintenance dose
JP2022514645A (ja) 2018-12-20 2022-02-14 アイミューン セラピューティクス，インコーポレイテッド ピーナツ経口免疫療法において投与が欠落した場合の投与スケジュール
JP2022519817A (ja) 2019-01-23 2022-03-25 ビフォー ブランズ，インコーポレイテッド 混合アレルゲン組成物の製造方法
JP7574222B2 (ja) 2019-05-10 2024-10-28 ソシエテ・デ・プロデュイ・ネスレ・エス・アー ピーナツアレルギー患者の生活の質を改善するための方法
JP2023506028A (ja) * 2019-12-23 2023-02-14 プロタ セラピューティクス ピーティワイ リミテッド 医薬組成物
JP7756664B2 (ja) 2020-07-01 2025-10-20 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 経口免疫療法のための医療スタッフ配置の決定
CN112890199B (zh) * 2021-02-27 2022-05-31 中国农业科学院油料作物研究所 一种稳态高效调节免疫功能组合物及其制备和应用
WO2022185284A1 (en) * 2021-03-05 2022-09-09 Société des Produits Nestlé S.A. Methods of making and assessing allergenic tree nut compositions
JP7628047B2 (ja) 2021-03-31 2025-02-07 日本ハム株式会社 くるみタンパク質の検査用キットおよび検査方法
JP7556814B2 (ja) 2021-03-31 2024-09-26 日本ハム株式会社 くるみアレルゲンＪｕｇ ｒ ２タンパク質の抽出用試薬および抽出方法
EP4651893A2 (en) * 2023-01-17 2025-11-26 Société des Produits Nestlé S.A. Mixed nut allergen formulations and methods of making and using the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU641135B2 (en) * 1990-01-08 1993-09-16 Procter & Gamble Company, The Improved nut butter and nut solid milling process
US6197356B1 (en) * 1993-08-03 2001-03-06 Immunopath Profile, Inc. Process for preparing hypoallergenic foods
US20120164306A1 (en) * 1993-08-03 2012-06-28 Girsh Leonard S Process for preparing hypoallergenic and reduced fat foods
US7381434B2 (en) * 2003-04-08 2008-06-03 Herbalscience Llc Methods and compositions of Areca catechu
AR059729A1 (es) * 2006-03-03 2008-04-23 Specialty Protein Producers In Metodos para separar la grasa de materiales de soja y composiciones producidas con ello
JP2012240975A (ja) * 2011-05-20 2012-12-10 Nitto Denko Corp 医薬組成物及びゼリー状製剤
WO2013087119A1 (en) * 2011-12-16 2013-06-20 Hal Allergy Holding B.V. Pharmaceutical formulations and the use thereof for the treatment of peanut allergy
DK3482771T3 (da) * 2013-03-14 2023-03-20 Nestle Sa Fremstilling af jordnøddeformuleringer til oral desensibilisering
CN103535508A (zh) * 2013-10-22 2014-01-29 陕西天玉实业有限公司 核桃蛋白粉及其制备方法
MX393928B (es) * 2015-02-20 2025-03-24 Univ Leland Stanford Junior Composiciones alergénicas mixtas y métodos de uso de las mismas.
CN106165870B (zh) * 2016-07-08 2020-03-31 北京市农林科学院 核桃脱脂全粉及其制备方法与应用

Also Published As

Publication number Publication date
SG10201913846XA (en) 2020-03-30
EP3568027A1 (en) 2019-11-20
JP2022136170A (ja) 2022-09-15
CA3050093A1 (en) 2018-07-19
AU2023202625A1 (en) 2023-05-18
EP3568027A4 (en) 2020-11-11
IL267882A (en) 2019-09-26
JP2020514306A (ja) 2020-05-21
CN110381749A (zh) 2019-10-25
WO2018132733A1 (en) 2018-07-19
AU2018207167A1 (en) 2019-07-25
US20180200361A1 (en) 2018-07-19
SG11201906301UA (en) 2019-08-27
US20230233672A1 (en) 2023-07-27

Similar Documents

Publication Publication Date Title
MX2019008419A (es) Métodos de fabricación de harinas de nueces y formulaciones para inmunoterapia oral.
EP4275760A3 (en) Egg protein formulations and methods of manufacture thereof
ZA202004764B (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
WO2018190719A3 (en) Anti-sirp alpha antibodies
MX2019014009A (es) Metodos mejorados para la elaboracion de terapias celulares adoptivas.
CA166702S (en) Blood pressure monitor
CA166574S (en) Blood pressure monitor
EP4299122A3 (en) Compositions and methods for treating skin and mucous membrane diseases
EP4279579A3 (en) Methods and compositions for natural killer cells
HK1218621A1 (zh) 用於治疗慢性炎症和炎性疾病的组合物及方法
MX2016008448A (es) Conjugados de var2csa-farmaco.
MX2019015311A (es) Composiciones de ésteres de ácido cannabidiólico y usos de las mismas.
WO2014210037A3 (en) A composition of mesenchymal stem cells
PH12017500217B1 (en) Anti-orai1 antibody
MX2017013564A (es) Formulaciones de glucopiranosil lipido a y alérgenos de cacahuete para administración sublingual.
MX2021005157A (es) Composiciones, metodos para hacer y utilizar extracto de salvado de arroz.
CA176338S (en) Gel cushion insole
MX2015016603A (es) Composiciones de corticosteroides.
MX2021003908A (es) Polipeptidos de accion prolongada y metodos para su produccion y administracion.
PH12019501133A1 (en) Manufacturing optimization of gl-2045, a multimerizing stradomer
MY186185A (en) Encapsulated fillings
GB201117490D0 (en) Anti-inflammatory compounds
PH12017501979A1 (en) Pharmaceutical compound
PH12018502207A1 (en) Methods of manufacturing nutritional formulations
MX2017010670A (es) Alimento en forma de gel para lechoncillos, metodo para manufacturar el mismo y uso.